Viatris, Kindeva get FDA nod for generic version of AstraZeneca’s asthma drug
Breyna is indicated for asthma patients, aged six years and above, along with maintenance treatment of patients with…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Mar 22
Breyna is indicated for asthma patients, aged six years and above, along with maintenance treatment of patients with…
14 Mar 22
Lynparza is said to be the first and only FDA approved adjuvant therapy for patients with gBRCAm, HER2-negative…
14 Mar 22
The NMPA approval was based on positive results from a single-arm, multi-centre, open-label Phase 2 trial that evaluated…
07 Mar 22
In the Phase 3 CheckMate -816 trial, Opdivo plus platinum-doublet chemotherapy showed superior outcomes compared to platinum-doublet chemotherapy…
01 Mar 22
In the CARTITUDE-1 study, 98% of patients with RRMM responded to a one-time treatment with Carvykti, while 78%…
28 Feb 22
In the CLEAR/KEYNOTE-581 trial, Keytruda plus Lenvima significantly reduced the risk of disease progression or death by 61%,…
25 Feb 22
The FDA approval is supported by results from the Phase 3 EMPEROR-Preserved trial in which Jardiance showed a…
25 Feb 22
Covifenz leverages CoVLP technology, comprises recombinant spike (S) glycoprotein, and is co-administered with GSK’s pandemic adjuvant
24 Feb 22
Sanofi and GSK’s vaccine is said to have induced superior immune responses and a favourable safety profile, both…
22 Feb 22
Corbevax is a receptor-binding domain (RBD) protein sub-unit Covid-19 vaccine and is India’s first indigenously developed Covid-19 vaccine